Skip to main content
Premium Trial:

Request an Annual Quote

Decrease in Pharma Business Drives Response Genetics' Q3 Revenues Down 10 Percent

NEW YORK (GenomeWeb News) – Driven by a downswing in revenues from its pharmaceutical clients, Response Genetics today said that third-quarter revenues dipped 10 percent year over year to $5.1 million.

Revenues for the three months ended Sept. 30 compare to $5.6 million for the third quarter a year ago.

While revenues derived from sales of its ResponseDx genetic tests increased 10 percent to $3.3 million from $3 million a year ago, pharma-related revenues slid 31 percent to $1.8 million from $2.6 million.

The firm's spending on R&D increased to $452,734, up 42 percent from $319,271 a year ago, while SG&A costs of $3.5 million represented a 3 percent decrease from $3.6 million in Q3 a year ago.

Response Genetics' net loss for the quarter increased to $1.4 million, or $.07 per share, from a net loss of $1.1 million, or $.06 per share, a year ago. The Los Angeles-based molecular diagnostics firm reported a foreign currency exchange loss of $25,593 during the quarter, compared to a gain of $9,045 for the third quarter of 2010.

As of Sept. 30, the company had $2.5 million in cash and cash equivalents.

During the quarter, Response Genetics added seven people to its sales staff, interim CEO Denise McNairn said in a statement, adding that more additions are expected. The company also said that it is progressing in its search for a permanent CEO and "a number of strong candidates" have been identified.

The Scan

Could Mix It Up

The US Food and Drug Administration is considering a plan that would allow for the mixing-and-matching of SARS-CoV-2 vaccines and boosters, the New York Times says.

Closest to the Dog

New Scientist reports that extinct Japanese wolf appears to be the closest known wild relative of dogs.

Offer to Come Back

The Knoxville News Sentinel reports that the University of Tennessee is offering Anming Hu, a professor who was acquitted of charges that he hid ties to China, his position back.

PNAS Papers on Myeloid Differentiation MicroRNAs, Urinary Exosomes, Maize Domestication

In PNAS this week: role of microRNAs in myeloid differentiation, exosomes in urine, and more.